Mechanistic analysis of luteolin in mitigating dry age-related macular degeneration through network pharmacology and experimental validation
8.4
来源：
Nature
关键字：
in silico screening
发布时间：
2025-10-30 04:05
摘要：
Luteolin, a natural flavonoid, shows promise in mitigating dry age-related macular degeneration (AMD) through its antioxidant properties and modulation of key signaling pathways. This study combines network pharmacology with experimental validation, identifying 213 therapeutic targets and demonstrating luteolin's protective effects on retinal pigment epithelial (RPE) cells. The findings suggest that luteolin enhances cell viability, reduces oxidative stress, and stabilizes mitochondrial function, positioning it as a potential therapeutic candidate for dry AMD management.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+医疗健康领域符合度
business_impact
0.5分+市场拓展
scientific_rigor
1.5分+有具体实验数据
timeliness_innovation
1.5分+重大创新
investment_perspective
2.5分+早期研发
market_value_relevance
1.0分+高发疾病
team_institution_background
0.5分+知名机构背景
technical_barrier_competition
0.4分+技术壁垒一般
关键证据
Luteolin significantly improved sodium iodate-induced loss of viability in ARPE-19 cells.
Network pharmacology identified 213 overlapping targets of luteolin involved in the treatment of dry AMD.
Molecular docking analyses confirmed the high-affinity binding of luteolin to core proteins.
真实性检查
否
AI评分总结
Luteolin, a natural flavonoid, shows promise in mitigating dry age-related macular degeneration (AMD) through its antioxidant properties and modulation of key signaling pathways. This study combines network pharmacology with experimental validation, identifying 213 therapeutic targets and demonstrating luteolin's protective effects on retinal pigment epithelial (RPE) cells. The findings suggest that luteolin enhances cell viability, reduces oxidative stress, and stabilizes mitochondrial function, positioning it as a potential therapeutic candidate for dry AMD management.